Income Statement Alkem Laboratories Limited

Equities

ALKEM

INE540L01014

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 12:29:44 2024-09-17 am EDT			5-day change	1st Jan Change
6,281.00 ^INR	-1.20%		-0.06%	+20.41%

Sep. 13	Alkem Reportedly Joins $3 Billion Race for JB Chem as Torrent Pauses Talks	CI
Sep. 02	Alkem Laboratories Limited Receives Orders Passed by Statutory Authority Under the Goods and Services Tax Act, 2017	CI

f6a561f998605cb28d75964d6d640624._4mCP4ruT_BVeQ3lVEINrUAFRBiQHUMrUKHe6h7IAJM.lsfPWcCKHroQTG66Mgp77i1tEXbxRxB8H865kDODNquppOt--5oahAEpTA

Published financial data: ALKEM LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Revenues	83.44B	88.65B	106B	116B	127B
Other Revenues, Total	-	-	-	-	-
Total Revenues	83.44B	88.65B	106B	116B	127B
Cost of Goods Sold, Total	34.23B	35.75B	42.81B	50.21B	50.64B
Gross Profit	49.21B	52.9B	63.54B	65.79B	76.03B
Selling General & Admin Expenses, Total	20.85B	19.81B	25.77B	29.73B	30.33B
R&D Expenses	-	-	-	-	-
Depreciation & Amortization - (IS)	2.52B	2.74B	3.03B	3.1B	2.99B
Other Operating Expenses	13.18B	13.61B	17.3B	19.76B	23.04B
Other Operating Expenses, Total	36.55B	36.15B	46.1B	52.59B	56.36B
Operating Income	12.66B	16.75B	17.43B	13.2B	19.68B
Interest Expense, Total	-466M	-399M	-309M	-809M	-804M
Interest And Investment Income	632M	901M	1.23B	1.71B	2.76B
Net Interest Expenses	166M	503M	918M	902M	1.95B
Currency Exchange Gains (Loss)	45.5M	458M	-16.5M	-189M	-335M
Other Non Operating Income (Expenses)	-82.6M	-45.3M	-24.2M	-12.8M	12.2M
EBT, Excl. Unusual Items	12.79B	17.66B	18.31B	13.9B	21.31B
Gain (Loss) On Sale Of Investments	-171M	370M	114M	309M	152M
Gain (Loss) On Sale Of Assets	12.7M	388M	19.7M	-124M	-31.8M
Asset Writedown	-32.7M	-	-11.2M	-1.05B	-577M
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	10.5M	17.4M	-618M
EBT, Incl. Unusual Items	12.6B	18.42B	18.44B	13.05B	20.23B
Income Tax Expense	1.1B	2.24B	1.64B	2.98B	2.12B
Earnings From Continuing Operations	11.49B	16.18B	16.8B	10.07B	18.11B
Net Income to Company	11.49B	16.18B	16.8B	10.07B	18.11B
Minority Interest	-222M	-328M	-347M	-226M	-157M
Net Income - (IS)	11.27B	15.85B	16.46B	9.84B	17.96B
Net Income to Common Incl Extra Items	11.27B	15.85B	16.46B	9.84B	17.96B
Net Income to Common Excl. Extra Items	11.27B	15.85B	16.46B	9.84B	17.96B
Per Share Items
Net EPS - Basic	94.26	132.57	137.63	82.31	150.19
Basic EPS - Continuing Operations	94.26	132.57	137.63	82.31	150.19
Basic Weighted Average Shares Outstanding	120M	120M	120M	120M	120M
Net EPS - Diluted	94.26	132.57	137.63	82.31	150.19
Diluted EPS - Continuing Operations	94.26	132.57	137.63	82.31	150.19
Diluted Weighted Average Shares Outstanding	120M	120M	120M	120M	120M
Normalized Basic EPS	64.99	89.59	92.81	70.75	110.06
Normalized Diluted EPS	64.99	89.59	92.81	70.75	110.06
Dividend Per Share	25	30	34	25	40
Payout Ratio	31.82	21.12	25.43	23.08	29.96
Supplemental Items
EBITDA	14.86B	19.16B	20.12B	15.89B	22.27B
EBITA	12.85B	16.91B	17.6B	13.38B	19.86B
EBIT	12.66B	16.75B	17.43B	13.2B	19.68B
EBITDAR	14.92B	19.21B	20.2B	15.99B	22.37B
Total Revenues (As Reported)	84.49B	90.98B	108B	118B	130B
Effective Tax Rate - (Ratio)	8.77	12.18	8.89	22.84	10.46
Total Current Taxes	3.23B	3.97B	3.62B	2.74B	4.22B
Total Deferred Taxes	-2.12B	-1.72B	-1.98B	241M	-2.11B
Normalized Net Income	7.77B	10.71B	11.1B	8.46B	13.16B
Interest on Long-Term Debt	86.8M	69M	75.7M	77M	79.6M
Non-Cash Pension Expense	76.3M	89.8M	276M	128M	189M
Supplemental Operating Expense Items
Marketing Expenses	5.66B	3.46B	5.97B	8.19B	8.06B
Selling and Marketing Expenses	5.66B	3.46B	5.97B	8.19B	8.06B
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	4.74B	5.34B	5.69B	5.41B	5.25B
Net Rental Expense, Total	63.6M	50.6M	74.2M	98.4M	101M
Imputed Operating Lease Interest Expense	17.79M	9.18M	8.22M	31.34M	46.05M
Imputed Operating Lease Depreciation	45.81M	41.42M	65.98M	67.06M	54.75M
Maintenance & Repair Expenses, Total	784M	766M	1B	1.14B	1.27B
Stock-Based Comp., SG&A Exp. (Total)	1.5M	1.1M	-	-	189M
Total Stock-Based Compensation	1.5M	1.1M	-	-	189M

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.76B	1.74B	2.32B	2.74B	4.55B
Short Term Investments	1.16B	14.12B	9.42B	7.34B	36.71B
Trading Asset Securities, Total	1.68B	1.67B	1.38B	1.36B	1.44B
Total Cash And Short Term Investments	4.6B	17.54B	13.13B	11.43B	42.7B
Accounts Receivable, Total	16.49B	16.07B	18.88B	21.44B	22.85B
Other Receivables	2.34B	2.83B	1.61B	1.78B	1.66B
Notes Receivable	280M	312M	202M	67.7M	90.7M
Total Receivables	19.11B	19.21B	20.69B	23.29B	24.6B
Inventory	18.19B	23.12B	30.06B	26.08B	26.61B
Prepaid Expenses	318M	304M	564M	444M	499M
Other Current Assets, Total	12.74B	9.11B	19.92B	26.05B	9.7B
Total Current Assets	54.96B	69.29B	84.35B	87.3B	104B
Gross Property Plant And Equipment	33.9B	35.74B	39.13B	37.35B	40.57B
Accumulated Depreciation	-6.16B	-8.67B	-11.47B	-12.22B	-15B
Net Property Plant And Equipment	27.74B	27.06B	27.66B	25.14B	25.57B
Long-term Investments	1.12B	1.59B	8.8B	5.25B	4.05B
Goodwill	3.98B	3.95B	4.03B	4.13B	4.17B
Other Intangibles, Total	984M	844M	722M	794M	576M
Loans Receivable Long-Term	106M	110M	80.2M	80.2M	-
Deferred Tax Assets Long-Term	9.33B	11.08B	13.09B	13.02B	15.15B
Other Long-Term Assets, Total	1.21B	1.27B	1.95B	1.86B	2.12B
Total Assets	99.43B	115B	141B	138B	156B
Liabilities
Accounts Payable, Total	9.54B	10.69B	11.73B	11.65B	17.48B
Accrued Expenses, Total	5.24B	6.44B	7.94B	9.25B	8.51B
Short-term Borrowings	15.04B	16.36B	25.71B	13.07B	11.73B
Current Portion of Long-Term Debt	381M	368M	1.2M	300K	13.4M
Current Portion of Leases	218M	216M	216M	192M	152M
Current Income Taxes Payable	456M	189M	163M	234M	550M
Unearned Revenue Current, Total	19.4M	16.8M	12.4M	10.5M	39.1M
Other Current Liabilities	1.55B	1.75B	2.28B	2.67B	1.48B
Total Current Liabilities	32.43B	36.04B	48.05B	37.07B	39.95B
Long-Term Debt	676M	279M	93.8M	-	400M
Long-Term Leases	916M	697M	665M	703M	1.89B
Unearned Revenue Non Current	97.7M	88.3M	79.2M	88M	258M
Pension & Other Post Retirement Benefits	1.18B	1.2B	1.55B	1.7B	1.93B
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	1.04B	1.31B	1.78B	3.65B	4.18B
Total Liabilities	36.34B	39.61B	52.22B	43.22B	48.6B
Common Stock, Total	239M	239M	239M	239M	239M
Retained Earnings	61.04B	73.54B	85.81B	90.39B	103B
Comprehensive Income and Other	330M	-11.8M	328M	-178M	-88M
Total Common Equity	61.61B	73.77B	86.38B	90.45B	103B
Minority Interest	1.48B	1.81B	2.09B	3.9B	4.02B
Total Equity	63.09B	75.58B	88.47B	94.35B	107B
Total Liabilities And Equity	99.43B	115B	141B	138B	156B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	120M	120M	120M	120M	120M
ECS Total Common Shares Outstanding	120M	120M	120M	120M	120M
Book Value / Share	515.26	616.96	722.44	756.52	862.46
Tangible Book Value	56.64B	68.97B	81.63B	85.53B	98.38B
Tangible Book Value Per Share	473.7	576.83	682.69	715.32	822.79
Total Debt	17.23B	17.92B	26.68B	13.97B	14.18B
Net Debt	12.62B	383M	13.55B	2.54B	-28.51B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.63B	1.9B	2.26B	2.44B	2.77B
Debt Equivalent Oper. Leases	509M	405M	594M	787M	806M
Minority Interest, Total (Incl. Fin. Div)	1.48B	1.81B	2.09B	3.9B	4.02B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	5.02B	6.65B	8.03B	8.06B	8.69B
Inventories - Work In Process, Total	857M	1.09B	1.34B	1.64B	1.47B
Inventories - Finished Goods, Total	12.31B	15.39B	20.68B	16.38B	16.45B
Land - (BS)	2.02B	2.01B	1.37B	1.37B	1.47B
Buildings, Total	8.63B	8.81B	9.67B	8.79B	10.23B
Machinery, Total	18.33B	19.73B	22.55B	21.71B	23.69B
Full Time Employees	14.33K	15.36K	16.97K	16.87K	17.43K
Accumulated Allowance for Doubtful Accounts (Supple)	424M	512M	464M	438M	914M

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	11.27B	15.85B	16.46B	9.84B	17.96B
Depreciation & Amortization - CF	2.25B	2.48B	2.77B	2.8B	2.68B
Amortization of Goodwill and Intangible Assets - (CF)	187M	167M	169M	183M	184M
Depreciation & Amortization, Total	2.44B	2.65B	2.94B	2.99B	2.86B
Amortization of Deferred Charges, Total - (CF)	91.5M	97.6M	104M	118M	134M
(Gain) Loss From Sale Of Asset	-12.6M	-388M	14.3M	124M	31.8M
(Gain) Loss on Sale of Investments - (CF)	171M	-370M	35.2M	-309M	-152M
Asset Writedown & Restructuring Costs	32.7M	-	11.2M	1.05B	992M
Stock-Based Compensation (CF)	1.5M	1.1M	-	-	189M
Provision and Write-off of Bad Debts	102M	-32.1M	27.8M	48.8M	524M
Other Operating Activities, Total	-1.77B	-1.75B	-3.02B	-304M	-2.54B
Change In Accounts Receivable	-2.57B	-258M	-2.22B	-1.35B	-2.22B
Change In Inventories	-2.82B	-4.98B	-6.73B	4.73B	-734M
Change In Accounts Payable	-37.4M	2.12B	3.34B	145M	5.25B
Change in Other Net Operating Assets	-1.04B	-301M	154M	-264M	-2.82B
Cash from Operations	5.85B	12.65B	11.11B	16.82B	19.48B
Capital Expenditure	-3.63B	-1.95B	-3.39B	-2.33B	-2.59B
Sale of Property, Plant, and Equipment	154M	105M	109M	32M	725M
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	351M	-	-	-
Investment in Marketable and Equity Securities, Total	-4.45B	-9.29B	-12.05B	1.95B	-10.61B
Other Investing Activities, Total	517M	794M	980M	1.47B	2.39B
Cash from Investing	-7.41B	-9.99B	-14.35B	1.13B	-10.08B
Short Term Debt Issued, Total	7.84B	1.78B	8.82B	-	-
Long-Term Debt Issued, Total	-	-	-	-	400M
Total Debt Issued	7.84B	1.78B	8.82B	-	400M
Short Term Debt Repaid, Total	-	-	-	-12.69B	-5.21B
Long-Term Debt Repaid, Total	-2B	-618M	-405M	-333M	-323M
Total Debt Repaid	-2B	-618M	-405M	-13.02B	-5.53B
Issuance of Common Stock	-	-	-	-	-
Common Dividends Paid	-3.59B	-3.35B	-4.18B	-2.27B	-5.38B
Common & Preferred Stock Dividends Paid	-3.59B	-3.35B	-4.18B	-2.27B	-5.38B
Special Dividend Paid	-	-	-	-2.99B	-
Other Financing Activities, Total	-1.46B	-536M	-436M	676M	-938M
Cash from Financing	792M	-2.72B	3.8B	-17.61B	-11.45B
Foreign Exchange Rate Adjustments	40.1M	36.7M	25M	71M	-20.5M
Net Change in Cash	-731M	-17.2M	580M	416M	-2.07B
Supplemental Items
Cash Interest Paid	651M	536M	401M	905M	913M
Cash Income Tax Paid (Refund)	3.59B	4.01B	3.97B	2.73B	4.07B
Levered Free Cash Flow	-6.47B	12.35B	-6.09B	5.55B	31.08B
Unlevered Free Cash Flow	-6.18B	12.6B	-5.89B	6.06B	31.58B
Change In Net Working Capital	12.99B	-988M	16.44B	2.96B	-18.69B
Net Debt Issued / Repaid	5.84B	1.17B	8.42B	-13.02B	-5.13B

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	8.72	9.75	8.52	5.93	8.38
Return on Total Capital	10.88	12.04	10.44	7.38	10.71
Return On Equity %	19.35	23.33	20.48	11.01	17.98
Return on Common Equity	19.43	23.42	20.55	11.13	18.55
Margin Analysis
Gross Profit Margin %	58.97	59.67	59.75	56.72	60.02
SG&A Margin	24.99	22.34	24.23	25.63	23.94
EBITDA Margin %	17.81	21.61	18.92	13.7	17.58
EBITA Margin %	15.4	19.08	16.55	11.53	15.68
EBIT Margin %	15.17	18.89	16.39	11.38	15.53
Income From Continuing Operations Margin %	13.77	18.25	15.8	8.68	14.3
Net Income Margin %